Authors reported that salvianolic acid B (SAB), a polyphenol compound extracted from the roots of Salvia miltiorrhiza, is a CD36 antagonist that blocks the uptake of oxidised lipids in macrophages, making CD36 a potential target for intervention in metabolic disorders. Here, CD36 is linked to metabolic disease.